Perhaps it will have a positive impact for KNL then. Maybe not so much for those whose graphite hasn’t undergone the same level of testwork as KNL’s.
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial